Synapse - Genitourinary Oncology Service

Search Within

Genitourinary Oncology Service

Results (5694)

Phase III, randomized, placebo-controlled study of everolimus in patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients intolerant of prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy

Meeting Abstract

Hutson, T. E.; Bracarda, S.; Escudier, B.; Porta, C.; Figlin, R. A.; Calvo, E.; Grunwald, V.; Ravaud, A.; Kpamegan, E.; Motzer, R. J.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Clinicopathologic findings in Jamaican men with prostate cancer

Meeting Abstract

Kampel, L. J.; Tse, K.; Joseph, M.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Antitumor activity of MDV3100 in pre- and post-docetaxel advanced prostate cancer: Long-term follow-up of a phase I/II study

Meeting Abstract

Higano, C. S.; Beer, T. M.; Taplin, M.; Efstathiou, E.; Anand, A.; Hirmand, M.; Fleisher, M.; Scher, H. I.; for the Prostate Cancer Clinical Trials Consortium
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase II trial of gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients (Pts) with advanced/metastatic urothelial carcinoma (UC)

Meeting Abstract

Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Multi-institutional quality-of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder: Phase I

Meeting Abstract

Feifer, A.; Taylor, J. M.; Shouery, M.; Steinberg, G. D.; Stadler, W. M.; Schoenberg, M.; Zlotta, A.; Lerner, S. P.; Bajorin, D. F.; Bochner, B.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Everolimus in metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients (pts) with one versus two prior vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) therapies enrolled in the phase III RECORD-1 study

Meeting Abstract

Figlin, R. A.; Calvo, E.; Motzer, R. J.; Hutson, T. E.; Oudard, S.; Porta, C.; Grunwald, V.; Ravaud, A.; Kpamegan, E.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Germline single-nucleotide polymorphisms (SNPs) associated with response of urothelial carcinoma (UC) to platinum-based therapy: The role of the host

Meeting Abstract

Gallagher, D.; Joseph, V.; Garcia-Grossman, I. R.; Przybylo, J. A.; Riches, J. C.; Ostrovnaya, I.; Hamilton, R.; Milowsky, M. I.; Offit, K.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Genomic analysis of circulating tumor cells to evaluate predictive biomarkers

Meeting Abstract

Danila, D. C.; Anand, A.; Yao, J.; Gierszewska, M.; Kramer, M.; Fleisher, M.; Sawyers, C. L.; McCombie, W. R.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Alterations in genes regulating cell cycle and apoptosis in high-grade urothelial carcinoma

Meeting Abstract

Al-Ahmadie, H.; Iyer, G.; Lin, O.; Gopalan, A.; Fine, S.; Tickoo, S.; Reuter, V. E.; Bajorin, D. F.; Milowsky, M. I.; Solit, D. B.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Cancer of the testis

Book Section

Bosl, G. J.; Feldman, D. R.; Bajorin, D. F.; Sheinfeld, J.; Motzer, R. J.; Reuter, V. E.; Kollmeier, M. A.; Chaganti, R. S. K.
In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 9th ed (2011)

Fulltext@MSK | Save